InsidersTradesSigma
Total declarations
Company
▲ Purchases (6 ops.)
▼ Sales (2 ops.)
Insider track record
OtherDisclosed buys
6
Disclosed sells
2
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the detailed record of transactions filed by Wagner Paul A., Autre. Insider active across 1 company, notably Forte Biosciences, Inc.. Cumulatively, 22 filings have been recorded. Breakdown: 6 buys · 2 sells. Total volume traded: €7.4m. Activity tracked since 7 September 2021. The latest transaction was filed on 1 July 2026 (Retenue fiscale). Regulator: SEC (Form 4). All data is free.
Declarations22 total
1,250 sharesCommon StockSEC:0001612842-26-000010:0
98 shares@ US$21.320.0004% mcap0.0% of flowCommon StockSEC:0001612842-26-000010:1
1,250 sharesCommon StockSEC:0001612842-26-000006:0
98 shares@ US$24.860.0% of flowCommon StockSEC:0001612842-26-000006:1
1,250 shares0Common StockSEC:0001415889-25-009694:0
1,250 shares0Common StockSEC:0001415889-25-000141:0
1,250 shares0Common StockSEC:0001415889-24-024494:0
31,250 shares0Common StockSEC:0001415889-24-019122:0
31,250 shares0Common StockSEC:0001415889-24-009857:0
31,250 shares0Common StockSEC:0001209191-24-000316:0
10,000 shares@ US$0.75250.1% of flowCommon StockSEC:0001209191-23-059297:0
Ideal exit: 13 Sept 2024 (T+270)
10,520 shares@ US$0.69880.1% of flowCommon StockSEC:0001209191-23-058867:0
Ideal exit: 8 Sept 2024 (T+270)
25,000 shares@ US$0.64750.2% of flowCommon StockSEC:0001209191-23-058404:0
Ideal exit: 6 Sept 2024 (T+270)
36,203 shares@ US$0.58470.3% of flowCommon StockSEC:0001209191-23-057989:0
Ideal exit: 2 Sept 2024 (T+270)
5,300 shares@ US$0.440.0% of flowCommon StockSEC:0001209191-23-056522:0
Ideal exit: 16 Aug 2024 (T+270)
31,250 shares0Common StockSEC:0001209191-23-051476:0
247,524 shares@ US$1.013.0% of flowCommon StockSEC:0001209191-23-044280:0
31,250 shares0Common StockSEC:0001209191-23-040961:0
31,250 shares0Common StockSEC:0001209191-23-023083:0
55,976 shares@ US$1.03030.7% of flowCommon StockSEC:0001209191-22-061903:0
Ideal exit: 11 Sept 2023 (T+270)
1,000,000 shares@ US$4.34710.78% mcap50.0% of flowCommon StockSEC:0000899243-21-035344:0
1,000,000 shares@ US$4.347147.8% of flowCommon StockSEC:0000899243-21-035344
22 of 22 declarations
About Wagner Paul A.
Paul A. Wagner is associated with Forte Biosciences, Inc. Although his exact role is not specified, he is involved in activities that support the company's mission. Forte Biosciences is an innovation-driven healthcare company. Paul contributes to the company's vision and objectives through his expertise and commitment.
